Clinical Trials
3 trialsNCT02194738 2026-05-29
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
Phase NA Active not recruiting
NCT03769129 2024-06-25
Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
Second Affiliated Hospital of Guangzhou Medical University
Phase NA Recruiting
NCT04393883 2020-11-30
A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Unknown